Lasa Supergenerics Limited (LASA.BO)
INR 29.0
(-0.82%)
INR 29.0
(-0.82%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 190.43 Million INR | 36.97% |
| 2022 | 139.03 Million INR | 20.92% |
| 2021 | 114.97 Million INR | -33.38% |
| 2020 | 172.58 Million INR | -34.39% |
| 2019 | 263.04 Million INR | -16.76% |
| 2018 | 315.99 Million INR | -25.18% |
| 2017 | 422.34 Million INR | 26.23% |
| 2016 | 334.58 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 199.75 Million INR | 0.0% |
| 2023 Q4 | 190.43 Million INR | 0.0% |
| 2023 FY | 190.43 Million INR | 36.97% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q2 | 120.58 Million INR | 0.0% |
| 2022 FY | 139.03 Million INR | 20.92% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 139.03 Million INR | 0.0% |
| 2021 Q2 | 177.74 Million INR | 0.0% |
| 2021 FY | 114.97 Million INR | -33.38% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 114.97 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 172.58 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 186.33 Million INR | 0.0% |
| 2020 FY | 172.58 Million INR | -34.39% |
| 2019 Q2 | 229.16 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 263.04 Million INR | -16.76% |
| 2019 Q4 | 263.04 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q4 | 315.99 Million INR | 0.0% |
| 2018 FY | 315.99 Million INR | -25.18% |
| 2018 Q2 | 390.22 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q1 | - INR | 0.0% |
| 2017 Q2 | 385.12 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 422.34 Million INR | 0.0% |
| 2017 FY | 422.34 Million INR | 26.23% |
| 2016 FY | 334.58 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Ajanta Pharma Limited | 8.28 Billion INR | 97.701% |
| Amrutanjan Health Care Limited | 289.04 Million INR | 34.117% |
| Sigachi Industries Limited | 707.2 Million INR | 73.072% |
| Bal Pharma Limited | 878.11 Million INR | 78.313% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -82.099% |
| Medico Remedies Limited | 163.37 Million INR | -16.565% |
| Venus Remedies Limited | 1.21 Billion INR | 84.351% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Alpa Laboratories Limited | 136.65 Million INR | -39.356% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 97.315% |
| Shilpa Medicare Limited | 3.44 Billion INR | 94.479% |
| Aarti Drugs Limited | 4.85 Billion INR | 96.081% |
| Lupin Limited | 49.53 Billion INR | 99.616% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.806% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 99.447% |
| Windlas Biotech Limited | 621.89 Million INR | 69.378% |
| Suven Life Sciences Limited | 7.08 Million INR | -2587.848% |
| Eris Lifesciences Limited | 1.89 Billion INR | 89.926% |
| Valiant Laboratories Limited | 100.15 Million INR | -90.141% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 96.21% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 94.706% |
| Ipca Laboratories Limited | 24.71 Billion INR | 99.229% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 83.922% |
| Achyut Healthcare Limited | 568 Thousand INR | -33427.113% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.807% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 86.779% |
| RPG Life Sciences Limited | 1.01 Billion INR | 81.145% |
| Mankind Pharma Limited | 15.53 Billion INR | 98.774% |
| Laurus Labs Limited | 18.45 Billion INR | 98.968% |
| Piramal Pharma Limited | 21.75 Billion INR | 99.125% |
| Syncom Formulations (India) Limited | 210.81 Million INR | 9.668% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 99.164% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 98.841% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 99.242% |
| Unichem Laboratories Limited | 7.04 Billion INR | 97.298% |
| Sequent Scientific Limited | 3.46 Billion INR | 94.5% |
| Novartis India Limited | 448.6 Million INR | 57.549% |
| Wanbury Limited | 360.23 Million INR | 47.136% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 91.763% |
| Wockhardt Limited | 6.4 Billion INR | 97.024% |
| Themis Medicare Limited | 705.74 Million INR | 73.017% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -26.981% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 98.523% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 97.143% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.7% |
| Divi's Laboratories Limited | 31.84 Billion INR | 99.402% |
| NATCO Pharma Limited | 7 Billion INR | 97.281% |
| Gufic Biosciences Limited | 2 Billion INR | 90.501% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 95.518% |
| Ind-Swift Limited | 640.91 Million INR | 70.287% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 82.547% |
| FDC Limited | 3.88 Billion INR | 95.103% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -94.392% |
| Granules India Limited | 13 Billion INR | 98.536% |
| Medicamen Biotech Limited | 593.75 Million INR | 67.927% |
| Alkem Laboratories Limited | 26.61 Billion INR | 99.284% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 91.643% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -646.888% |
| Brooks Laboratories Limited | 96.1 Million INR | -98.146% |
| Megasoft Limited | - INR | -Infinity% |
| ZIM Laboratories Limited | 812.62 Million INR | 76.566% |
| Strides Pharma Science Limited | 11.26 Billion INR | 98.309% |
| Neuland Laboratories Limited | 3.5 Billion INR | 94.566% |
| Morepen Laboratories Limited | 2.48 Billion INR | 92.34% |
| Hikal Limited | 3.03 Billion INR | 93.73% |
| Indoco Remedies Limited | 3.53 Billion INR | 94.606% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 97.038% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -377.518% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 84.598% |
| Hester Biosciences Limited | 755.81 Million INR | 74.804% |